CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Midazolam injectionWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)

Name (Synonyms) Correlation
drug1647 MELT-100 Wiki 1.00
drug366 BVRS-GamVac-Combi Wiki 1.00
drug1523 Ketamine Injectable Product Wiki 1.00
drug3408 placebo Wiki 0.27

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D013577 Syndrome NIH 0.10
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 A Pilot Phase 1, Randomized, Single-Dose, 6-Sequences, 3-Period, Crossover Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual Tablet) and Intravenous Midazolam or Ketamine in Healthy Volunteers

Comparative Bioavailability study testing MELT-100 (midazolam and ketamine sublingual tablet) and IV midazolam or ketamine in healthy volunteers

NCT04485702 Healthy Volunteers Drug: Midazolam injection Drug: Ketamine Injectable Product Drug: MELT-100

Primary Outcomes

Measure: Peak Plasma Concentration (Cmax)

Time: 24 hours

Measure: Area under the plasma concentration versus time curve (AUC)

Time: 24 hours

Measure: Time to peak plasma concentration (Tmax)

Time: 24 hours

No related HPO nodes (Using clinical trials)